Annexin Pharmaceuticals AB

Quick facts

Phase 2 pipeline

• ANXV · Psychiatry
  ANXV is a small molecule that modulates the activity of certain proteins involved in anxiety disorders.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Annexin Pharmaceuticals AB portfolio CI brief
• Annexin Pharmaceuticals AB pipeline updates RSS